(Q40903029)

24 September 2017

In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin (English)

1 reference

24 September 2017

0 references

0 references

Lorraine Jones-Brando

1

1 reference

24 September 2017

John D'Angelo

2

1 reference

24 September 2017

Gary H Posner

3

1 reference

24 September 2017

Robert Yolken

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

23 October 2006

1 reference

Antimicrobial Agents and Chemotherapy

24 September 2017

1 reference

24 September 2017

50

1 reference

24 September 2017

12

1 reference

24 September 2017

4206-4208

1 reference

A medicinal chemistry perspective on artemisinin and related endoperoxides

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Toxoplasma gondii: from animals to humans

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Management of toxoplasmosis.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Antimalarial activity of new water-soluble dihydroartemisinin derivatives

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Arteether, a new antimalarial drug: synthesis and antimalarial properties

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693994

Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17060514

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00793-06

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

17060514

1 reference